The impact of smoking on adherence to treatment for latent tuberculosis infection
<p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI tre...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | BMC Public Health |
Online Access: | http://www.biomedcentral.com/1471-2458/6/66 |
id |
doaj-d12db13a84ac4e34a0dfd0560a15c05d |
---|---|
record_format |
Article |
spelling |
doaj-d12db13a84ac4e34a0dfd0560a15c05d2020-11-24T21:36:27ZengBMCBMC Public Health1471-24582006-03-01616610.1186/1471-2458-6-66The impact of smoking on adherence to treatment for latent tuberculosis infectionSteensma ColinRocher IsabelleLavigne MélanieBrassard Paul<p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen, thus increasing their risk of developing active disease. We thus documented the impact of smoking on adherence to LTBI treatment.</p> <p>Method</p> <p>Between 1998 and 2000, a convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status. Level of adherence to LTBI treatment was tested for associations with socio-demographic profile, and smoking status</p> <p>Results</p> <p>320 patients were recruited, and 302 (94%) completed the questionnaire. Smoking prevalence was 21%. 72% of patients were adherent to LTBI treatment. Women (OR = 2.0; 95% CI: 1.2–3.3) and non-smokers (OR = 1.8; 95% CI: 1.0–3.3) were associated with adherence to LTBI treatment. Only gender was found as an independent predictor of adherence after adjusting for age and smoking status (OR = 1.9; 95% CI: 1.06–3.3).</p> <p>Conclusion</p> <p>Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.</p> http://www.biomedcentral.com/1471-2458/6/66 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Steensma Colin Rocher Isabelle Lavigne Mélanie Brassard Paul |
spellingShingle |
Steensma Colin Rocher Isabelle Lavigne Mélanie Brassard Paul The impact of smoking on adherence to treatment for latent tuberculosis infection BMC Public Health |
author_facet |
Steensma Colin Rocher Isabelle Lavigne Mélanie Brassard Paul |
author_sort |
Steensma Colin |
title |
The impact of smoking on adherence to treatment for latent tuberculosis infection |
title_short |
The impact of smoking on adherence to treatment for latent tuberculosis infection |
title_full |
The impact of smoking on adherence to treatment for latent tuberculosis infection |
title_fullStr |
The impact of smoking on adherence to treatment for latent tuberculosis infection |
title_full_unstemmed |
The impact of smoking on adherence to treatment for latent tuberculosis infection |
title_sort |
impact of smoking on adherence to treatment for latent tuberculosis infection |
publisher |
BMC |
series |
BMC Public Health |
issn |
1471-2458 |
publishDate |
2006-03-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen, thus increasing their risk of developing active disease. We thus documented the impact of smoking on adherence to LTBI treatment.</p> <p>Method</p> <p>Between 1998 and 2000, a convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status. Level of adherence to LTBI treatment was tested for associations with socio-demographic profile, and smoking status</p> <p>Results</p> <p>320 patients were recruited, and 302 (94%) completed the questionnaire. Smoking prevalence was 21%. 72% of patients were adherent to LTBI treatment. Women (OR = 2.0; 95% CI: 1.2–3.3) and non-smokers (OR = 1.8; 95% CI: 1.0–3.3) were associated with adherence to LTBI treatment. Only gender was found as an independent predictor of adherence after adjusting for age and smoking status (OR = 1.9; 95% CI: 1.06–3.3).</p> <p>Conclusion</p> <p>Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.</p> |
url |
http://www.biomedcentral.com/1471-2458/6/66 |
work_keys_str_mv |
AT steensmacolin theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT rocherisabelle theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT lavignemelanie theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT brassardpaul theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT steensmacolin impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT rocherisabelle impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT lavignemelanie impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection AT brassardpaul impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection |
_version_ |
1725941108168458240 |